Court Skeptical of Bid to Cut Abortion Pill Access

Court skeptical of bid to cut abortion pill access

A U.S. appeals court on Wednesday appeared skeptical of a bid by the Republican-led state of Louisiana to curtail access to the abortion drug mifepristone by blocking a 2023 rule that allowed the medication to be prescribed via telemedicine and…

Fifth Circuit Questions Louisiana’s Standing in Mifepristone Case

Judges ask whether the FDA’s 2023 mail and telehealth rule led to abortions in a state that already bans the procedure.

Louisiana AG returns to 5th Circuit seeking end to telehealth abortion meds

Louisiana Attorney General Liz Murrill made a return appearance before a federal appellate court Wednesday in her effort to strike down Biden-era health policy that allows abortion drug prescriptions without an in-person doctor’s visit.

Chaos and Confusion Around Women’s Health

Earlier today, the Fifth Circuit Court of Appeals heard oral arguments in State of Louisiana et al. v. Food and Drug Administration et al., a federal lawsuit targeting mifepristone, one of many in a long line of attacks on abortion pills. In this case, the court is being asked to force the FDA to reimpose in-person dispensing requirements, effectively blocking all avenues for obtaining mifepristone — including by mail, via telehealth, and at pha…